Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30).
作者信息
Kong Sung Hye, Koo Bo Kyung, Moon Min Kyong
机构信息
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
出版信息
Diabetes Metab J. 2017 Apr;41(2):152-153. doi: 10.4093/dmj.2017.41.2.152.
Abstract
摘要
相似文献
1
Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30).回应：中等强度他汀类药物治疗韩国2型糖尿病患者血脂异常的疗效（《糖尿病代谢杂志》2017年；41:23 - 30）
Diabetes Metab J. 2017 Apr;41(2):152-153. doi: 10.4093/dmj.2017.41.2.152.
2
Letter: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30).信函：中等强度他汀类药物对韩国2型糖尿病患者血脂异常的治疗效果（《糖尿病代谢杂志》2017年；第41卷：第23 - 30页）
Diabetes Metab J. 2017 Apr;41(2):150-151. doi: 10.4093/dmj.2017.41.2.150.
3
Response: Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data (Diabetes Metab J 2017;41:393-404).回应：基于标准化临床数据的长期患有糖尿病视网膜病变的韩国2型糖尿病患者的特征：一项研究（《糖尿病与代谢杂志》2017年；41:393 - 404）
Diabetes Metab J. 2017 Dec;41(6):494-495. doi: 10.4093/dmj.2017.41.6.494.
4
Response: predictive clinical parameters for the therapeutic efficacy of sitagliptin in korean type 2 diabetes mellitus (diabetes metab j 2011;35:159-65).反应：西他列汀治疗韩国2型糖尿病疗效的预测临床参数（《糖尿病与代谢杂志》2011年；35:159 - 165）
Diabetes Metab J. 2011 Jun;35(3):300-1. doi: 10.4093/dmj.2011.35.3.300. Epub 2011 Jun 30.
5
Response: genome-wide association study identifies two novel Loci with sex-specific effects for type 2 diabetes mellitus and glycemic traits in a korean population (diabetes metab j 2014;38:375-87).回应：全基因组关联研究在韩国人群中发现了两个对2型糖尿病和血糖特征具有性别特异性影响的新基因座（《糖尿病与代谢杂志》2014年；38:375 - 87）。
Diabetes Metab J. 2014 Dec;38(6):487-8. doi: 10.4093/dmj.2014.38.6.487.
6
Re-Evaluation of Efficacy of Moderate-Intensity Statins in Korean Patients with Type 2 Diabetes Mellitus.韩国2型糖尿病患者中高强度他汀类药物疗效的重新评估
Diabetes Metab J. 2017 Feb;41(1):20-22. doi: 10.4093/dmj.2017.41.1.20.
7
Letter: Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data (Diabetes Metab J 2017;41:393-404).信函：基于标准化临床数据的韩国长期2型糖尿病视网膜病变患者的特征：一项研究（《糖尿病代谢杂志》2017年；41:393 - 404）
Diabetes Metab J. 2017 Dec;41(6):492-493. doi: 10.4093/dmj.2017.41.6.492.
8
Letter: predictive clinical parameters for the therapeutic efficacy of sitagliptin in korean type 2 diabetes mellitus (diabetes metab j 2011;35:159-65).信函：西他列汀治疗韩国2型糖尿病疗效的预测性临床参数（《糖尿病与代谢杂志》2011年；35:159 - 165）
Diabetes Metab J. 2011 Jun;35(3):298-9. doi: 10.4093/dmj.2011.35.3.298. Epub 2011 Jun 30.
9
Response: Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005 (Diabetes Metab J 2012;36:43-55).回应：韩国成年人血脂异常患病率：1998 - 2005年韩国国民健康与营养调查（《糖尿病代谢杂志》2012年；36卷：43 - 55页）
Diabetes Metab J. 2012 Apr;36(2):165-6. doi: 10.4093/dmj.2012.36.2.165. Epub 2012 Apr 17.
10
Response: the prevalence of peripheral arterial disease in korean patients with type 2 diabetes mellitus attending a university hospital (diabetes metab j 2011;35:543-50).回应：一所大学医院中2型糖尿病韩国患者外周动脉疾病的患病率（《糖尿病代谢杂志》2011年；35:543 - 50）
Diabetes Metab J. 2012 Feb;36(1):77-8. doi: 10.4093/dmj.2012.36.1.77. Epub 2012 Feb 17.
本文引用的文献
1
Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus.中等强度他汀类药物治疗韩国2型糖尿病患者血脂异常的疗效
Diabetes Metab J. 2017 Feb;41(1):23-30. doi: 10.4093/dmj.2017.41.1.23. Epub 2016 Dec 16.
2
Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States.瑞舒伐他汀在美国居住的白种人和亚洲人群中的药代动力学与药物遗传学
Eur J Clin Pharmacol. 2015 Mar;71(3):329-40. doi: 10.1007/s00228-014-1800-0. Epub 2015 Jan 30.
3
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会心血管风险评估指南：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.
4
Safety and efficacy of statins in Asians.他汀类药物在亚洲人群中的安全性与有效性。
Am J Cardiol. 2007 Feb 1;99(3):410-4. doi: 10.1016/j.amjcard.2006.08.051. Epub 2006 Dec 15.
5
Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.居住在同一环境中的白种人和亚洲受试者中瑞舒伐他汀的药代动力学和药物遗传学。
Clin Pharmacol Ther. 2005 Oct;78(4):330-41. doi: 10.1016/j.clpt.2005.06.013.
Zotero 插件